NCT01388283View on ClinicalTrials.gov

Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

May 31, 2004

Study Completion Date

June 30, 2011

Conditions
Preeclampsia
All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT01388283 - Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia | Biotech Hunter | Biotech Hunter